Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” in this Registration Statement (FormS-3) and related Prospectus of Turning Point Therapeutics, Inc. for the registration of its common stock, preferred stock, debt securities, and warrants and to the incorporation by reference therein of our report dated March 17, 2020, with respect to the financial statements of Turning Point Therapeutics, Inc., included in its Annual Report (Form10-K) for the year ended December 31, 2019, filed with the Securities and Exchange Commission.
/s/ Ernst & Young LLP |
San Diego, California
May 15, 2020